Join the Invega group to help and get support from people like you.
Invega News
Long-Acting Injected Antipsychotics Help People With Schizophrenia Stay Out of Hospital
WEDNESDAY, Jan. 31, 2024 – For people with schizophrenia hospitalized after a psychotic episode, getting a long-acting antipsychotic injection works far better than pills to keep them from returning...
FDA Medwatch Alert: Paliperidone Extended-Release Tablets 3mg by Teva Pharmaceuticals: Recall - Dissolution Test Failure
ISSUE: Teva Pharmaceuticals USA, Inc. (Teva) initiated a voluntary recall to retail-level on 05/31/2017 for one lot of Paliperidone Extended-Release Tablets, 3mg, 90 count bottles, lot 1160682A,...
FDA Approves Invega Trinza (paliperidone palmitate) Four-Times-A-Year Treatment for Schizophrenia
TITUSVILLE, N.J., May 19, 2015 – There’s a new treatment option for schizophrenia – Invega Trinza (three-month paliperidone palmitate), the first and only schizophrenia medication to be administered j...
FDA Approves sNDA for Invega Sustenna (paliperidone palmitate) for Schizoaffective Disorder
TITUSVILLE, N.J., Nov. 13, 2014 /PRNewswire/ – Janssen Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Applications (sNDAs)...
Invega Approved as Treatment for Schizophrenia in Adolescents
TITUSVILLE, N.J., April 11, 2011 /PRNewswire/ – The U.S. Food and Drug Administration (FDA) on April 6 approved Invega (paliperidone) extended-release tablets for the treatment of schizophrenia in...
FDA Medwatch Alert: Antipsychotics, Conventional and Atypical
[Posted 06/16/2008] FDA notified healthcare professionals that both conventional and atypical antipsychotics are associated with an increased risk of mortality in elderly patients treated for...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Schizoaffective Disorder, Schizophrenia